Lobbying firm
REGENXBIO
Gene Therapy Biotechnology Company
Filings
24
Clients
1
Total income
—
Lobbyists
1
Years active
2018–2023
Filings counts every document on the register, amendments included. Income is the fees reported to clients, counting the current version of each report once.
Income by year
Fees reported, $ thousands
2018 to 2023
Filings
24 filings, newest first.
| Filing | Client | Income | Expenses |
|---|---|---|---|
|
4th Quarter - Termination 4th Quarter 2023
|
REGENXBIO | — income | $91,000 expenses |
|
3rd Quarter - Report 3rd Quarter 2023
|
REGENXBIO | — income | $94,000 expenses |
|
2nd Quarter - Report 2nd Quarter 2023
|
REGENXBIO | — income | $90,000 expenses |
|
1st Quarter - Report 1st Quarter 2023
|
REGENXBIO | — income | $163,000 expenses |
|
4th Quarter - Report 4th Quarter 2022
|
REGENXBIO | — income | $70,000 expenses |
|
3rd Quarter - Report 3rd Quarter 2022
|
REGENXBIO | — income | $70,000 expenses |
|
2nd Quarter - Report 2nd Quarter 2022
|
REGENXBIO | — income | $82,000 expenses |
|
1st Quarter - Report 1st Quarter 2022
|
REGENXBIO | — income | $150,000 expenses |
|
4th Quarter - Report 4th Quarter 2021
|
REGENXBIO | — income | $60,000 expenses |
|
3rd Quarter - Amendment 3rd Quarter 2021
|
REGENXBIO | — income | $75,000 expenses |
Clients
Everyone this filer has reported for, with the reports filed and the income they disclose.
| Client | Reports | Income |
|---|---|---|
| REGENXBIO | 22 | — |
Lobbyists
Everyone named on this filer's reports, with the government post they most recently disclosed here.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRUCE ARTIM | Senate Judiciary Committee Staff Member 1995-2006; (Chief Counsel and Staff Director 2003-04); Intellectual Property Subcommittee - Chief Counsel and Staff Director 2005-06) |
From reports filed under the Lobbying Disclosure Act. A firm reports income from each client; an organisation lobbying for itself reports its own expenses instead. Each figure links to the filing it comes from.